Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ketorolac tromethamine 30mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
|
Ketorolac tromethamine 15mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
|
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
|
Ketorolac trometamol 15mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
|
Ketorolac tromethamine 30mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
|
Ketorolac trometamol 10mg/mL injection solution 1mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
|
Ketorolac tromethamine 30mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
|
Product containing precisely ketorolac trometamol 15.8 milligram/1 actuation conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
|
Product containing precisely ketorolac trometamol 5 milligram/1 milliliter conventional release eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 5 milligram/1 milliliter conventional release eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 10 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 10 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 30 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 30 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 10 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 10 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 4.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 4 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 4 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 15.8 milligram/1 actuation conventional release nasal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 15.8 milligram/1 actuation conventional release nasal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Ketorolac trometamol 5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Ketorolac trometamol 5 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 10 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |
Product containing precisely ketorolac trometamol 10 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ketorolac trometamol |
Inferred relationship |
Some |
1 |